NASA’s Artemis II Mission Launches; Dulcolax Included in Astronaut Medical Kit
New Delhi: NASA’s Artemis II mission marks a historic step as humans prepare to travel once again to lunar orbit. The 10-day mission is not only focused on exploration but also on maintaining astronauts’ overall health—including digestive well-being. As part of this effort, the widely known Opella brand product Dulcolax has been included in NASA’s official medical list and first-aid kit to help astronauts manage constipation in space.
In India, Dulcolax was rebranded as Dulcoflex in 2017.
While space travel is extraordinary, the human digestive system continues to follow Earth-based biological processes. In microgravity conditions, intestinal movement slows down significantly, and changes occur in the gut microbiome. Limited physical activity and specialized diets make constipation a common issue among astronauts. This is why NASA relies on solutions that are proven, predictable, and highly reliable.
Dulcolax is the only brand included in NASA’s formulary and first-aid kit specifically used to relieve constipation and related symptoms such as bloating, straining, and hard stools. Its consistent presence on the International Space Station (ISS) over the years highlights the trust built around the product over decades.
Dulcolax bisacodyl tablets work by stimulating natural bowel movements, helping restore normal digestive function. The medication is known for delivering reliable results, typically beginning to take effect within approximately six hours. It provides gentle relief without causing dependency—an essential factor in environments where reliability is critical.
Nupur Gurbaxani, Director – Brand & Innovation at Opella India, said, “Being part of a NASA mission is a testament to the decades-long trust placed in our brand by healthcare professionals and consumers. It reflects our commitment to delivering dependable solutions that work everywhere—from homes on Earth to space missions.”
Reliability is crucial in space—and equally important on Earth, where stress, travel, or lifestyle changes can disrupt digestion. From everyday life to lunar orbit, when the body needs support, Dulcolax aims to provide effective relief.
In India, the Dulcoflex bisacodyl portfolio is available in multiple formats to meet different needs:
- 5 mg tablets: Provide predictable, gentle overnight relief within 6–8 hours
- 5 mg suppositories: Fast, mess-free relief suitable for children (0–10 years)
- 10 mg suppositories: Quick, effective option for adults (10+ years)
This development highlights how even the smallest aspects of human health are carefully managed in space exploration, ensuring astronauts remain fit for mission success.